glp-1 fda approved for pcos The dual impact of receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials Weight loss drugs could help
Description
This lack of research raises concerns because non-diabetic patients face different risks and benefits than diabetic patients
The severity of nausea can vary depending on the person
FAQs What are the long-term side effects of GLP-1 medications
2025 May;641(8061):192-201
